INGALLS & SNYDER LLC 13D and 13G filings for ImmunoPrecise Antibodies Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-27 10:33 am Purchase |
2024-02-13 | 13G | ImmunoPrecise Antibodies Ltd. IPA |
INGALLS & SNYDER LLC | 1,317,819 5.010% |
264,633 (+25.13%) |
Filing |
| 2023-07-07 3:22 pm Purchase |
2023-06-29 | 13D | ImmunoPrecise Antibodies Ltd. IPA |
INGALLS & SNYDER LLC | 1,053,186 4.220% |
1,053,186 (New Position) |
Filing |